Duquesne
RVMD · Medicine & biotech

Revolution Medicines

Develops pills for hard-to-treat cancers like pancreatic cancer.
Bought more
Duquesne owns 399,587 shares of Revolution Medicines, worth about $75 million. That’s $2 of every $100 they have in stocks. Between April and June they bought 83,727 more (up 27%).
Mar 31
315,860
Jun 30
399,587

The numbers

Shares they own
399,587
Change since Mar 31
+83,727
+26.5%
Shares on Mar 31
315,860
Value on Jun 30, 2026
$74,835,000
about $75 million
Share of their money
1.7%
$2 of every $100 · 17th of 85
Price per share on Jun 30
$187.28
Cost of the shares they added
about $16 million
at the Jun 30 price
Kind
Shares
More about Revolution Medicines
The value uses the price on Jun 30, 2026. The fund may have paid a different price.
Not investment advice. Holdings come from public SEC reports and the funds’ own letters, and can be up to 4½ months old. How this works